Acomplia

RIMONABANT SIDE EFFECTS Obesity is at an increasing rate, and no age group is immune, as society is ever increasing in a more sedentary lifestyle. Health problems are increasing especially in the area of weight and weight related illnesses. Regardless there are side effects with medications and these must be looked at. The possible side effects that Acomplia can lead to include (buy rimonabant,although not everybody gets them,cheap online pills)

Nausea, dizziness, mood changes, infections and infestations, metabolism and nutrition disorders: anorexia, decreased appetite, nervous system disorders disturbance in attention, gastrointestinal disorders, dry mouth, vomiting, trouble with sleeping, depression, irritability, diarrhea, anxiety, itching, excessive sweating, muscle cramps or spasm, fatigue, bruising, tendon pain and inflammation (buy cheap rimonabant,tendonitis), memory loss, back pain (buy rimonabant,sciatica), altered sensitivity of the hands and feet, hot flush, fall, influenza, and joint sprain.

It has been reported by some that some of the side effects seem to subside once adjustment to the drug is made. Acomplia could be less severe than what someone would experience with many other weight loss medications. Its proven effectiveness in weightloss and its tested ability to regulate healthy blood pressure, blood sugar and cholesterol levels could be a large benefit for its users.Some concern about the side effects of the drug on ones mental state may have the FDA taking some time before ever approving it to be sold in the USA.

Information on Acomplia® (Rimonabant) (Possibly Zimulti®)

In a clinical study, a group of patients where treated for 12 months with 20mg of rimonabant (Buy Rimonabant,Acomplia or Zimultion low cost online). And lost an average 20lbs verses the placebo group that lost 5 lbs. About 75% lost over 5% of their body weight and about 44% lost more than 10% of their body weight. The study also took into consideration some cardiovascular risks and found significant benefits including a 23% increase in “Good Cholesterol” levels (HDL-cholesterol - a high level seems to protect against heart attack.) There was an average reduction of 15% in triglycerides (buy rimonabant,the chemical form in which most fat exists in the body and are associated with cholesterol).

Comments from health care professionals:

“Acomplia’s been given to 13,000 people but you just don’t completely know what happens when you give it to a million.”
Dr. Louis J. Aronne, New York Hospital - Cornell Medical Center, quoted on June 28, 2006 by Bloomberg

“If there was a pill available that was safe, effective and made it easy to lose any weight at all, there would be a truly massive market.”
Dr. Steve Bloom, researcher at Imperial College in London, quoted on June 28, 2006 by Bloomberg (buy cheap rimonabant online)

“We come up with new drugs on the drawing board all the time, but rarely do they work the way we think they will. This one did. I think the drug has incredible potential.”
Dr. Elbert Glover of West Virginia University Medical School quoted in the August 14, 2004 issue of Newsweek.

“Lifestyle interventions including exercise, behavior modification and reduced caloric intake should be mainstays in the battle against obesity. Unfortunately, there is no quick fix.”(buy rimonabant)
Dr. JoAnne Foody, cardiologist at Yale University in New Haven, Connecticut, quoted on June 28, 2006 by Bloomberg.

“Rimonabant shows a substantial weight reduction, and if that’s possible without side effects it could be promising. I have concerns about the idea you just buy a drug and that’s it, buying weight reduction instead of changing lifestyle habits.”
Dr.Otto Smiseth, a professor of medicine at University of Oslo, quoted on August 29. 2004 by Bloomberg.

“It will be very widely prescribed if found safe and effective in the remaining trials that are due to come out over the next year or two.”(buy rimonabant online)
Dr. Christopher Cannon, a cardiologist at Brigham and Women’s Hospital in Boston and an associate professor of medicine at Harvard University, quoted on August 29. 2004 by Bloomberg.